This causes tumour extravasation of the peptide and of co-administered payloads by a transendothelial endocytic mechanism [1,4,5,6] that resembles vascular endothelial growth factor-A (VEGF-A)-induced transport vesicles called vesiculo-vacuolar organelles [7]. The gene discussed is VEGFA; the disease is neoplasm.